TCM
BMY.RT

Taal Capital Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Taal Capital Management’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-350,000
Closed -$788K – 19
2020
Q3 		$788K Buy
350,000
+250,000
+250% +$563K 0.77% 16
2020
Q2 		$358K Buy
+100,000
New +$358K 0.39% 16